₹1,124.45-5.00 (-0.44%)
04:01 PM, 11-Jul-2025₹1,124.80-5.10 (-0.45%)
03:50 PM, 11-Jul-2025BSE : 524804
NSE : AUROPHARMA
Sector : Health care
ISIN Code : INE406A01037
Last Updated: 11-Jul-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 65,882 |
Traded Value (₹ Cr) | 2.24 |
Volume (Shares) | 19,952 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,592.55 |
52-Week High Date | 13-Sep-2024 |
52-Week Low (₹) | 994.35 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 1,592.55 |
All Time High Date | 13-Sep-2024 |
All Time Low (₹) | 0.56 |
All Time Low Date | 20-Nov-1996 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 65,902 |
EPS - TTM (₹) [C] | 59.49 |
P/E Ratio (X) [C] | 18.91 |
Face Value (₹) | 1 |
Latest Dividend (%) | 150.00 |
Latest Dividend Date | 20-Feb-2024 |
Dividend Yield (%) | - |
Book Value Share (₹) [C] | 557.29 |
P/B Ratio (₹) [C] | 2.02 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Quant Mid Cap Fund (G) | 677.36 | 59,69,000 | 7.41 |
Quant Mid Cap Fund (IDCW) | 677.36 | 59,69,000 | 7.41 |
Quant Mid Cap Fund - Direct (G) | 677.36 | 59,69,000 | 7.41 |
Quant Mid Cap Fund - Direct (IDCW) | 677.36 | 59,69,000 | 7.41 |
Mirae Asset Large & Midcap Fund - Regular (G) | 531.34 | 46,82,192 | 1.29 |
Mirae Asset Large & Midcap Fund - Regular (IDCW) | 531.34 | 46,82,192 | 1.29 |
Mirae Asset Large & Midcap Fund - Direct (IDCW) | 531.34 | 46,82,192 | 1.29 |
Mirae Asset Large & Midcap Fund - Direct (G) | 531.34 | 46,82,192 | 1.29 |
Quant Multi Cap Fund (G) | 479.25 | 42,23,250 | 4.73 |
Quant Multi Cap Fund (IDCW) | 479.25 | 42,23,250 | 4.73 |
Load more
Today's Low/High (₹) | 1,115.20 1,139.00 |
Week Low/High (₹) | 1,115.20 1,197.00 |
Month Low/High (₹) | 1,078.50 1,197.00 |
Year Low/High (₹) | 1,010.00 1,592.00 |
All time Low/High (₹) | 0.56 1,592.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -5.53% | -5.58% | -1.12% | -1.22% |
1 Month | -3.05% | -3.12% | -0.02% | 0.03% |
3 Month | 3.90% | 3.91% | 9.77% | 10.17% |
6 Month | -6.27% | -6.23% | 6.62% | 7.33% |
1 Year | -14.64% | -14.65% | 3.26% | 3.43% |
3 Year | 106.97% | 106.78% | 51.67% | 55.09% |
Vice Chairman & M.D. : Kambam Nityananda Reddy
Whole-time Director : M Madan Mohan Reddy
Non Executive Director : P V Ramprasad Reddy
Independent Director : Savita Mahajan
Independent Director : Girish Paman Vanvari
Non Executive Director : P Sarath Chandra Reddy
Independent Director : Santanu Mukherjee
Independent Director : Deepali Pant Joshi
Chairman & Independent Directo : M R Kumar
Non Executive Director : Satakarni Makkapati
Registered Office: Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet,Hyderabad,Telangana-500038 Ph: 91-40-23736370
1. What's the Aurobindo Pharma Ltd share price today?
Aurobindo Pharma Ltd share price was Rs 1,124.45 at 04:01 PM IST on 11th Jul 2025. Aurobindo Pharma Ltd share price was down by 0.44% from the previous closing price of Rs 1,129.45. Aurobindo Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Aurobindo Pharma Ltd stock?
The performance of the Aurobindo Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Aurobindo Pharma Ltd?
Aurobindo Pharma Ltd has a market capitalisation of Rs 65,882 crore.
4. What is Aurobindo Pharma Ltd's 52-week high/low share price?
The Aurobindo Pharma Ltd’s 52-week high share price is Rs 1,592.55 and 52-week low share price is Rs 994.35.
5. Is the Aurobindo Pharma Ltd profitable?
On a consolidated basis, Aurobindo Pharma Ltd reported a profit of Rs 902.83 crore on a total income of Rs 8,516.93 crore for the quarter ended 2025. For the year ended 2024, Aurobindo Pharma Ltd had posted a profit of Rs 3,168.97 crore on a total income of Rs 29,001.87 crore.
6. Which are Aurobindo Pharma Ltd’s peers in the Health care sector?
Aurobindo Pharma Ltd’s top 5 peers in the Health care sector are Zydus Lifesci., Lupin, Abbott India, Aurobindo Pharma, Glenmark Pharma., Alkem Lab, Glaxosmi. Pharma.
7. Who owns how much in Aurobindo Pharma Ltd?
Key changes to the Aurobindo Pharma Ltd shareholding are as follows: